New York, NY, August 18, 2013 --(PR.com
)-- Nanobodies are novel therapeutic antibodies that combine unique structural and functional prosperities of naturally-occurring heavy-chain antibodies. The Nanobody technology was originally developed following the discovery that camels and llamas possess fully functional antibodies that lack light chains. These heavy-chain antibodies contain a single variable domain (VHH) and two constant domains (CH2 and CH3). Importantly, the cloned and isolated VHH domain is a perfectly stable polypeptide harboring the full antigen-binding capacity of the original heavy-chain antibody.
Nanobodies are an extremely useful class of molecules for research, diagnostics and therapeutics in human and animal health. They can be used in a wide variety of fields, such as immunohistochemistry, immunomodulation, intracellular expression and biosensor-applications. As proteomics tools, they can be deployed for expression profiling, physical mapping of proteins, protein-protein interaction studies, functional analysis and (in) activation of genens.
high-target specificity and affinity
low inherent toxicity
have an almost limitless repertoire diversity
easy to manufacture
Recombinant Anti-Human CEA Nanobody
Recombinant Anti-Human Serum Albumin Nanobody
Recombinant Anti-Human PSA Nanobody
Recombinant Anti-Human MMP12 Nanobody
Recombinant Anti-Human IgE Nanobody
Recombinant Anti-Human RANKL Nanobody
Recombinant Anti-Human IL12 Nanobody
Recombinant Anti-Human CTLA4 Nanobody
There are more nanobody products at Creative Biomart, for details, please Contact